EVOKE PHARMA, INC. Interest Payable, Current
EVOKE PHARMA, INC. had Interest Payable, Current of $2.49 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2025-11-13
- 2025-09-30: Interest Payable, Current $2.49M.
- 2025-06-30: Interest Payable, Current $2.36M.
- 2025-03-31: Interest Payable, Current $2.24M.
- 2024-12-31: Interest Payable, Current $2.11M.
| Period end | Interest Payable, Current |
|---|---|
| 2025-09-30 | $2.49M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.36M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.24M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.11M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $1.99M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.86M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.74M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.61M 10-K · filed 2025-03-13 |